​

Curis (CRIS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Curis Revenue Highlights

Latest Revenue (Y)

$10.91M

Latest Revenue (Q)

$3.35M

Main Segment (Y)

Gross Royalty Revenue

Curis Revenue by Period

Curis Revenue by Year

DateRevenueChange
2024-12-31$10.91M8.83%
2023-12-31$10.02M-1.37%
2022-12-31$10.16M-4.57%
2021-12-31$10.65M-1.72%
2020-12-31$10.84M8.31%
2019-12-31$10.00M-4.07%
2018-12-31$10.43M5.35%
2017-12-31$9.90M31.50%
2016-12-31$7.53M-4.46%
2015-12-31$7.88M-19.96%
2014-12-31$9.84M-34.39%
2013-12-31$15.00M-11.61%
2012-12-31$16.97M14.97%
2011-12-31$14.76M-7.73%
2010-12-31$16.00M86.26%
2009-12-31$8.59M2.67%
2008-12-31$8.37M-48.95%
2007-12-31$16.39M9.73%
2006-12-31$14.94M148.83%
2005-12-31$6.00M21.20%
2004-12-31$4.95M-55.17%
2003-12-31$11.05M-39.92%
2002-12-31$18.39M1592.64%
2001-12-31$1.09M8.97%
2000-12-31$997.08K-68.96%
1999-12-31$3.21M-

Curis generated $10.91M in revenue during NA 2024, up 8.83% compared to the previous quarter, and up 109.04% compared to the same period a year ago.

Curis Revenue by Quarter

DateRevenueChange
2024-12-31$3.35M14.12%
2024-09-30$2.93M15.12%
2024-06-30$2.55M22.05%
2024-03-31$2.09M-22.63%
2023-12-31$2.70M-4.84%
2023-09-30$2.83M28.95%
2023-06-30$2.20M-4.35%
2023-03-31$2.30M-20.44%
2022-12-31$2.89M2.19%
2022-09-30$2.83M18.05%
2022-06-30$2.39M16.33%
2022-03-31$2.06M-34.39%
2021-12-31$3.13M3.16%
2021-09-30$3.04M32.94%
2021-06-30$2.29M4.43%
2021-03-31$2.19M-27.61%
2020-12-31$3.02M10.28%
2020-09-30$2.74M16.19%
2020-06-30$2.36M-12.88%
2020-03-31$2.71M-17.58%
2019-12-31$3.29M15.09%
2019-09-30$2.86M36.39%
2019-06-30$2.09M18.51%
2019-03-31$1.77M-35.86%
2018-12-31$2.75M-3.23%
2018-09-30$2.85M20.74%
2018-06-30$2.36M-4.46%
2018-03-31$2.47M-24.34%
2017-12-31$3.26M33.47%
2017-09-30$2.44M18.58%
2017-06-30$2.06M-3.28%
2017-03-31$2.13M-9.78%
2016-12-31$2.36M34.28%
2016-09-30$1.76M4.70%
2016-06-30$1.68M-2.66%
2016-03-31$1.73M-17.52%
2015-12-31$2.09M2.33%
2015-09-30$2.04M-1.80%
2015-06-30$2.08M25.58%
2015-03-31$1.66M-16.78%
2014-12-31$1.99M12.91%
2014-09-30$1.76M-63.24%
2014-06-30$4.80M273.75%
2014-03-31$1.28M-15.71%
2013-12-31$1.52M-78.84%
2013-09-30$7.20M33.26%
2013-06-30$5.40M520.17%
2013-03-31$871.43K-48.33%
2012-12-31$1.69M191.89%
2012-09-30$577.76K-86.72%
2012-06-30$4.35M-57.98%
2012-03-31$10.36M-26.49%
2011-12-31$14.09M9476.44%
2011-09-30$147.12K-62.55%
2011-06-30$392.87K194.20%
2011-03-31$133.54K33.16%
2010-12-31$100.29K-96.91%
2010-09-30$3.24M3187.21%
2010-06-30$98.63K-99.21%
2010-03-31$12.56M628.34%
2009-12-31$1.72M125.30%
2009-09-30$765.31K1109.73%
2009-06-30$63.26K-98.95%
2009-03-31$6.04M94.46%
2008-12-31$3.10M3479.87%
2008-09-30$86.72K-97.21%
2008-06-30$3.11M50.31%
2008-03-31$2.07M-82.00%
2007-12-31$11.48M-

Curis generated $3.35M in revenue during Q4 2024, up 14.12% compared to the previous quarter, and up 118.07% compared to the same period a year ago.

Curis Revenue Breakdown

Curis Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 24Dec 23Dec 22Dec 21Dec 20
Gross Royalty Revenue$10.90M$9.90M$10.28M--
Other Revenue---$1.00K$214.00K
Contra Revenue--$-116.00K$-101.00K$-103.00K
Royalty---$10.75M$10.72M

Curis's latest annual revenue breakdown by segment (product or service), as of Dec 24: Gross Royalty Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 25Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Sep 19Jun 19Mar 19
Reportable Segment$2.38M-------------------
Gross Royalty Revenue-$2.60M$2.70M$2.30M$2.30M$2.90M$2.84M$2.47M$2.06M$3.10M$3.06M$2.35M$2.19M$2.72M$2.45M$2.52M$2.91M$2.14M$2.14M-
Contra Revenue-----$-14.00K$-18.00K$-81.00K$-3.00K$-19.00K$-63.00K$2.00K$-22.00K$22.00K$-86.00K$-17.00K$-50.00K$-48.00K$-370.00K-
Other Revenue---------$1.00K-$3.00K--$211.00K-----

Curis's latest quarterly revenue breakdown by segment (product or service), as of Mar 25: Reportable Segment (100.00%).

Curis Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADAPAdaptimmune Therapeutics$178.03M$7.29M
DAWNDay One Biopharmaceuticals$131.16M$29.21M
CRISCuris$10.91M$3.35M
AFMDAffimed$8.28M$155.00K
XFORX4 Pharmaceuticals$2.56M$28.81M
CRVSCorvus Pharmaceuticals--
APTOAptose Biosciences--
ARTLArtelo Biosciences--
PDSBPDS Bio--
INZYInozyme Pharma--
LPTXLeap Therapeutics--
ALRNAileron Therapeutics--
TERNTerns Pharmaceuticals--
MREOMereo BioPharma Group--

CRIS Revenue FAQ

What is Curis’s yearly revenue?

Curis's yearly revenue for 2024 was $10.91M, representing an increase of 8.83% compared to 2023. The company's yearly revenue for 2023 was $10.02M, representing a decrease of -1.37% compared to 2022. CRIS's yearly revenue for 2022 was $10.16M, representing a decrease of -4.57% compared to 2021.

What is Curis’s quarterly revenue?

Curis's quarterly revenue for Q4 2024 was $3.34M, a 14.12% increase from the previous quarter (Q3 2024), and a 24.07% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $2.93M, a 15.12% increase from the previous quarter (Q2 2024), and a 3.46% increase year-over-year (Q3 2023). CRIS's quarterly revenue for Q2 2024 was $2.55M, a 22.05% increase from the previous quarter (Q1 2024), and a 15.89% increase year-over-year (Q2 2023).

What is Curis’s revenue growth rate?

Curis's revenue growth rate for the last 3 years (2022-2024) was 7.34%, and for the last 5 years (2020-2024) was 0.67%.

What are Curis’s revenue streams?

Curis's revenue streams in c 24 are Gross Royalty Revenue

What is Curis’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Curis was Gross Royalty Revenue. This segment made a revenue of $10.9M, representing 100.00% of the company's total revenue.